The Practice of Early Outpatient Treatment of Covid-19 illness

Three physicians discuss international experiences for the outpatient management of COVID-19, recognizing it is biphasic and the treatment approach is dependent on the phase of the disease. Drs. Bernstein, Chetty and McCullough had this conversation in April 2021.

Watch Now

Media, NEW: Early Treatment, NEW: Featured, NEW: Knowledge Base, NEW: Pandemic Management, NEW: Prevention & Treatment, NEW: Real World Data
anti-histamines, Canada, high-dose steroids, hydroxychloroquine, hypersensitivity reaction, inflammatory mediators, inflammatory phase, ivermectin, monteleuclast, multi-drug therapy, nutraceuticals, off-label medications, outpatient management, pathophysiology, PCR testing, South Africa, United States, Video, viral phase

Interview with Dr. Pelech regarding COVID-19 issues

Dr. Stephen Pelech provides an end of year review of the science that supports or refutes the public health policies imposed during the COVID-19 crisis.

Deanna McLeod Pt. 3: Big Pharma and Vaccine Conflict of Interest

Deanna McLeod’s interview on Open Mike with Mr. Michael Thiessen, on the topic of conflicts of interests surrounding the COVID-19 injections.

The Blind Spot in COVID-19 Vaccination Policies: Under Reported Adverse Events

In this peer-reviewed publication, Dr Patrick Provost examines the post-vaccination adverse events reporting system and the inherent weaknesses that may result in underreporting. Based on

The Practice of Early Outpatient Treatment of Covid-19 illness

The Practice of Early Outpatient Treatment of Covid-19 illness

Related Posts

Deanna McLeod Pt. 3: Big Pharma and Vaccine Conflict of Interest

Canadian Covid Care Alliance